Acute respiratory infections and antimicrobial resistance

American Journal of Nursing

Volumn 108, Issue 6, 2008, Pages 56-65

  Hart, Ann Marie ^a   Patti, Alison ^b   Noggle, Brendan ^c   Haller Stevenson, Erica ^c   Hines, Lisa B ^c  

^a UNIVERSITY OF WYOMING   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; DRUG UTILIZATION; HUMAN; MICROBIOLOGY; NURSE ATTITUDE; PATIENT EDUCATION; PATIENT SELECTION; PRESCRIPTION; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; TREATMENT FAILURE; UNITED STATES;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; NURSE'S ROLE; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PRESCRIPTIONS, DRUG; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TREATMENT FAILURE; UNITED STATES;

EID: 45849128379     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000324378.86779.bc     Document Type: Article

References (62)

1. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: A strategy for the 21st century overview of the updated CDC Plan. MMWR Recomm Rep 1998;47(RR15):1-14.
2. World Health Organization. Drug resistance threatens to reverse medical progress [press release]. WHO Information Office 2000 Jun 12. http://www.who.int/inf-pr-2000/en/ pr2000-41.html.
3. Smolinski MS, et al., editors. Microbial threats to health: emergence, detection, and response. Washington, D.C.: National Academies Press; 2003. http://www.nap.edu/ catalog.php?record-id=10636.
4. Ladd E. The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997-2001. J Am Acad Nurse Pract 2005;17(10):416-24.
5. Roumie CL, et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005; 20(8):697-702.
6. Stivers T, et al. Why do physicians think parents expect antibiotics? What parents report vs what physicians believe. J Fam Pract 2003;52(2):140-8.
7. Dosh SA, et al. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis. An UPRNet study. Upper Peninsula Research Network. J Fam Pract 2000;49(5):407-14.
8. McCaig L F, et al. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002;287(23):3096-102.
9. McCaig LF, et al. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003;9(4):432-7.
10. Finkelstein JA, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics 2003;112(3 Pt 1):620-7.
11. Jacobs R F. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J 2000;19(9):938-43.
12. Levy SB. The challenge of antibiotic resistance. Sci Am 1998; 278(3):46-53.
13. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 2000;133(2):128-35.
14. Mainous AG, 3rd, et al. Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization. J Fam Pract 1997;45(1):75-83.
15. Hart AM, et al. Balancing acts: deciding for or against antibiotics in acute respiratory infections. J Fam Pract 2006; 55(4):320-5.
16. Cadieux G, et al. Predictors of inappropriate antibiotic prescribing among primary care physicians. CMAJ 2007;177(8): 877-83.
17. Arnold SR, et al. Antibiotic prescribing for upper respiratory tract infection: the importance of diagnostic uncertainty. J Pediatr 2005;146(2):222-6.
18. Centers for Disease Control and Prevention. Active bacterial core surveillance report. Emerging infections program network, Streptococcus pneumoniae, 2006. Atlanta; 2007 May. Active Bacterial Core Surveillance Reports; http:// www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu06.pdf.
19. Pallares R, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317(1):18-22.
20. Block SL, et al. Penicillin-resistant Streptococcus pneumo-niae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14(9):751-9.
21. Dowell S F, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician 1997;55(5):1647-54, 1657-8.
22. Feikin DR, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90(2):223-9.
23. Lonks JR, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35(5):556-64.
24. Fuller JD, Low DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005;41(1):118-21.
25. Budnitz DS, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296(15):1858-66.
26. Centers for Disease Control and Prevention. Infant deaths associated with cough and cold medications-two states, 2005. MMWR Morb Mortal Wkly Rep 2007;56(1):1-4.
27. Gwaltney JM, Jr., et al. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA 1967;202(6):494-500.
28. Winther B, et al. Common cold model in children: symptom profile and duration of illness. Interscience Conference on Antimicrobial Agents and Chemotherapy; 1999 Sep 26-29; San Francisco: American Society for Microbiology; 1999. p. 418.
29. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993;110(1):145-60.
30. Rosenstein N, et al. The common cold - principles of judicious use of antimicrobial agents. Pediatrics 1998;101(1 Suppl):181-4.
31. Snow V, et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001;134(6):487-9.
32. Douglas RM, et al. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2007(3): CD000980.
33. Jackson JL, et al. Zinc and the common cold: a meta-analysis revisited. J Nutr 2000;130(5S Suppl):1512S-1515S.
34. Turner RB, et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005; 353(4):341-8.
35. Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2006;3:CD001728.
36. Guppy M P, et al. Advising patients to increase fluid intake for treating acute respiratory infections. Cochrane Database Syst Rev 2005(4):CD004419.
37. Pratter MR. Cough and the common cold: ACCP evidencebased clinical practice guidelines. Chest 2006;129(1 Suppl): 72S-74S.
38. Center for Drug Evaluation and Research. Public health advisory: nonprescription cough and cold medicine use in children. FDA recommends that over-the-counter (OTC) cough and cold products not be used for infants and children under 2 years of age. Rockville, MD: U.S. Food and Drug Administration; 2008 Jan 17. http://www.fda.gov/ cder/drug/advisory/cough-cold- 2008.htm.
39. Hickner JM, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Emerg Med 2001;37(6):703-10.
40. O'Brien KL, et al. Acute sinusitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101(1 Suppl):174-7.
41. Rosenfeld RM, et al. Clinical practice guideline: adult sinusitis. qOtolaryngol Head Neck Surg 2007;137(3 Suppl):S1-S31.
42. Bisno AL, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002;35(2):113-25.
43. Schwartz B, et al. Pharyngitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101(1 Suppl):171-4.
44. Danchin MH, et al. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics 2007;120(5):950-7.
45. Huovinen P, et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med 1989;110(8):612-6.
46. Komaroff AL, et al. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med 1986;1(1):1-7.
47. McIsaac WJ, et al. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ 1998; 158(1):75-83.
48. McIsaac WJ, et al. The validity of a sore throat score in family practice. CMAJ 2000;163(7):811-5.
49. Tanz RR, Shulman ST. Diagnosis and treatment of group a streptococcal pharyngitis. Semin Pediatr Infect Dis 1995; 6(2):69-78.
50. Cooper RJ, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134(6):509-17.
51. Kiderman A, et al. Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. Br J Gen Pract 2005;55(512):218-21.
52. Olympia R P, et al. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 2005;159(3):278-82.
53. Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 Suppl):95S-103S.
54. Freymuth F, et al. [Epidemiology and diagnosis of respiratory syncytial virus in adults]. Rev Mal Respir 2004;21(1):35-42.
55. Louie JK, et al. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin Infect Dis 2005;41(6):822-8.
56. Tiwari T, et al. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005;54(RR-14):1-16.
57. Macfarlane J, et al. Prospective study of the incidence, etiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56(2):109-14.
58. Gonzales R, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001;134(6):521-9.
59. O'Brien KL, et al. Cough illness/bronchitis - principles of judicious use of antimicrobial agents. Pediatrics 1998; 101(1 Suppl):178-81.
60. Guris D, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28(6): 1230-7.
61. Braman SS. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):138S-146S.
62. Centers for Disease Control and Prevention. National notifiable diseases surveillance system. 2008. http://www.cdc.gov/ ncphi/disss/nndss/ nndsshis.htm.